SHOVLIN ROBERT J. 4
4 · NEOGENOMICS INC · Filed Mar 3, 2021
Insider Transaction Report
Form 4
SHOVLIN ROBERT J.
Chief Operating Officer
Transactions
- Tax Payment
Common Stock
2021-03-01−742→ 147,528 total - Tax Payment
Common Stock
2021-03-02−608→ 146,920 total - Award
Stock Option (Right to Buy)
2021-03-02$53.17/sh+38,688$2,057,041→ 38,688 totalExercise: $53.17Exp: 2028-03-02→ Common Stock (38,688 underlying) - Award
Common Stock
2021-03-02+6,827→ 153,747 total
Holdings
- 56,271
Stock Option (Right to Buy)
Exercise: $28.33Exp: 2027-03-02→ Common Stock (56,271 underlying) - 50,173
Stock Option (Right to Buy)
Exercise: $19.60Exp: 2024-03-01→ Common Stock (50,173 underlying) - 96,167
Stock Option (Right to Buy)
Exercise: $8.03Exp: 2023-02-26→ Common Stock (96,167 underlying)
Footnotes (6)
- [F1]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 1, 2021 vesting of restricted stock.
- [F2]Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the March 2, 2021 vesting of restricted stock.
- [F3]On February 26, 2018, Mr. Shovlin was granted 288,500 stock options. These options vested ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Mr. Shovlin was granted 66,897 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Mr. Shovlin was granted 56,271 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F6]On March 2, 2021, Mr. Shovlin was granted 38,688 stock options. These options vest ratably over the first four anniversary dates of the grant date